US awards $232 mn to Ellume for at-home Covid test
Washington (AFP) - The US government is awarding nearly $232 million to the company Ellume USA LLC to scale up production of its rapid at-home Covid-19 diagnostic test, officials said Monday. Ellume's coronavirus home test kit received an emergency use authorization from the US Food and Drug Administration in December. The test, which uses a nasal swab and can be purchased without a prescription, can be performed at home with results reported via smartphone app within 15 minutes. It detects Covid-19 with 95 percent accuracy. "They can be used if you feel symptoms of Covid-19 and also for scree...